pmc logo image
Logo of aacAntimicrob Agents Chemother SubscriptionsAntimicrob Agents Chemother Web Site
Journal List > Antimicrob Agents Chemother > v.36(12); Dec 1992

Formats:
Antimicrob Agents Chemother. 1992 December; 36(12): 2761–2765.
PMCID: PMC245541
Copyright notice
Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
L Gerena, G T Bass, Sr, D E Kyle, A M Oduola, W K Milhous, and R K Martin
Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC 20307-5100.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
The emergence of chloroquine resistance in Plasmodium falciparum has necessitated the development of alternate strategies for chemotherapy and chemoprophylaxis. One approach has been the identification of drugs that do not possess any intrinsic antimalarial activity when used alone but that potentiate the effect of currently available antimalarial drugs, such as chloroquine. We identified fluoxetine hydrochloride (Prozac), a commonly prescribed antidepressant, as another resistance modulator for drug-resistant P. falciparum. Studies with chloroquine-resistant clones and isolates from various geographical locations confirmed our initial observations with a chloroquine-resistant P. falciparum clone, W2. Fluoxetine concentrations of 500 nM were found to effectively modulate chloroquine resistance by 66% in clone W2. In comparison, verapamil at similar concentrations was observed to modulate chloroquine resistance in clone W2 by 61%. Neither fluoxetine nor verapamil was observed to possess any innate antimalarial activity. These data augment the current description of the chloroquine resistance phenotype and may provide additional insights into lead-directed synthesis of new antimalarial drugs.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (818K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 2761
2761
icon of scanned page 2762
2762
icon of scanned page 2763
2763
icon of scanned page 2764
2764
icon of scanned page 2765
2765
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Basco LK, Ringwald P, Le Bras J. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann Trop Med Parasitol. 1991 Apr;85(2):223–228. [PubMed]
  • Beck WT. Multidrug resistance and its circumvention. Eur J Cancer. 1990 Apr;26(4):513–515. [PubMed]
  • Bitonti AJ, Sjoerdsma A, McCann PP, Kyle DE, Oduola AM, Rossan RN, Milhous WK, Davidson DE., Jr Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science. 1988 Dec 2;242(4883):1301–1303. [PubMed]
  • Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3847–3850. [PubMed]
  • Cowman AF, Karcz S, Galatis D, Culvenor JG. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol. 1991 Jun;113(5):1033–1042. [PubMed]
  • Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. [PubMed]
  • Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 1988 Sep 5;263(25):12163–12166. [PubMed]
  • Kelly MW, Perry PJ, Holstad SG, Garvey MJ. Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther Drug Monit. 1989;11(2):165–170. [PubMed]
  • Kyle DE, Oduola AM, Martin SK, Milhous WK. Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans R Soc Trop Med Hyg. 1990 Jul–Aug;84(4):474–478. [PubMed]
  • Martin SK, Oduola AM, Milhous WK. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 1987 Feb 20;235(4791):899–901. [PubMed]
  • Oduola AM, Weatherly NF, Bowdre JH, Desjardins RE. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol. 1988 Jun;66(1):86–95. [PubMed]
  • Peters W, Ekong R, Robinson BL, Warhurst DC, Pan XQ. Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet. 1989 Aug 5;2(8658):334–335. [PubMed]
  • Peters W, Robinson BL. The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium. Ann Trop Med Parasitol. 1991 Feb;85(1):5–10. [PubMed]
  • Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 1989 Jun 9;244(4909):1184–1186. [PubMed]
  • Ye ZG, Van Dyke K. Selective antimalarial activity of tetrandrine against chloroquine resistant Plasmodium falciparum. Biochem Biophys Res Commun. 1989 Feb 28;159(1):242–248. [PubMed]
  • Ye ZG, Van Dyke K, Castranova V. The potentiating action of tetrandrine in combination with chloroquine or qinghaosu against chloroquine-sensitive and resistant falciparum malaria. Biochem Biophys Res Commun. 1989 Dec 15;165(2):758–765. [PubMed]
  • Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol. 1988 Apr;33(4):454–462. [PubMed]
Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of
American Society for Microbiology (ASM)

PubMed articles by these authors